HIGHLIGHTS OF PRESCRIBING INFORMATION Extended Treatment In ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ... Get Document
HIGHLIGHTS OF PRESCRIBING INFORMATION ... - Allergan
BYSTOLIC tablets are triangular-shaped, biconvex, unscored, differentiated by color and are engraved with “ FL ” on one side and the number of mg (2 ½, 5, 10, or 20) on the other side. 4. ... Retrieve Here
See Full Prescribing Information For Complete Boxed Warning ...
FULL PRESCRIBING INFORMATION WARNING: HEPATOTOXICITY Severe and sometimes fatal hepatotoxicity has occurred in clinical trials [see Warnings and Precautions (5.1)]. Monitor hepatic function prior to and during treatment [see Warnings and Precautions (5.1)]. ... Read More
HIGHLIGHTS OF PRESCRIBING INFORMATION Age Group Dosage ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CUBICIN safely and effectively. See full prescribing information ... Fetch Doc
HIGHLIGHTS OF PRESCRIBING INFORMATION Interstitial Lung ...
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HYCAMTIN FOR INJECTION safely and effectively. ... Doc Retrieval
HIGHLIGHTS OF PRESCRIBING INFORMATION Infusion-related ...
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Invasive Aspergillosis CRESEMBA® is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [see Clinical Studies (14.1) and Clinical Pharmacology (12.4)]. 1.2 Invasive Mucormycosis ... Fetch Here
Of 4-6 Cycles. Following Completion Of Chemotherapy ...
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Locally Advanced or Metastatic Urothelial Carcinoma TECENTRIQ (atezolizumab) is indicated for the treatment of patients with locally advanced or ... Content Retrieval
Lynparza (olaparib) - Specialtydrug.magellanprovider.com
LYNPARZA (olaparib) Prior Auth Criteria Proprietary Information. Restricted Access – Do not disseminate or copy without approval. ©2018, Magellan Rx Management VII. References 1. Lynparza capsules [package insert]. Wilmington, DE; AstraZeneca Pharmaceuticals LP; August 2017. Accessed August 2017. 2. Lynparza tablets [package insert]. ... Doc Viewer
HIGHLIGHTS OF PRESCRIBING INFORMATION Proteinuria: Monitor ...
Refer to everolimus prescribing information for recommended everolimus dosing information. 2.4 Recommended Dosage for Hepatocellular Carcinoma (HCC) The recommended dosage of LENVIMA is based on actual body weight: • 12 mg for patients greater than or equal to 60 kg or • 8 mg for patients less than 60 kg. ... Fetch Full Source
Olaparib - Wikipedia
Olaparib (AZD-2281, trade name Lynparza) is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase (PARP), an enzyme involved in DNA repair. ... Read Article
PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/17/16 ...
Lynparza tablet. Package Insert. Revised by manufacturer 01/2018. Accessed 02-27-2018. Fax completed prior authorization request form to 602-864-3126 or email to pharmacyprecert@azblue.com. Call 866-325-1794 to check the status of a request. ... Retrieve Here
ToposarTM - Pfizer
TOPOSAR is contraindicated in patients who have demonstrated a previous hypersensitivity to it. WARNINGS Patients being treated with TOPOSAR must be frequently observed for myelosuppression both during and after therapy. Dose-limiting bone marrow suppression is the most significant toxicity associated with etoposide therapy. ... Retrieve Content
ZARXIO (filgrastim-sndz)
•ZARXIO is a biosimilar of the reference biologic NEUPOGEN® (filgrastim)1-3 – Filgrastim is a granulocyte colony-stimulating factor (G-CSF) analog used ... Doc Viewer
US-10674 LYNPARZA Consumer 2Lm Press Release
LYNPARZA was the first FDA-approved PARP inhibitor.1,9-11 Cancer happens when cells grow out of control. 12 Because of this growth, cancer cells have a higher risk of accumulating DNA damage. 13 To help fix this damage and survive, the cancer cells rely on several ... Get Content Here
DOSAGE FORMS AND STRENGTHS --------------------- See 17 F
TWINRIX is a vaccine indicated for active immunization against disease caused by hepa titis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons ... Access Document
Jakafi Prescribing Information
Jakafi is a kinase inhibitor indicated for treatment of patients with: • intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. ... Return Doc
LYNPARZA (olaparib) - Caremark
Lynparza is a poly ADP-ribose polymerase (PARP) inhibitor that blocks enzymes involved in repairing damaged DNA. Lynparza is intended for women with heavily pretreated ovarian cancer that is associated with defective BRCA genes, or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. ... Read More
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CYRAMZAsafely and effectively. See full prescribing information ... Get Doc
No comments:
Post a Comment